LOS ANGELES, March 10, 2005 (PRIMEZONE) -- Universal Detection Technology (OTCBB:UDTT) today announced that it has installed an Anthrax Smoke Detector (ASD) unit at a major hotel in Orange County, Calif. The detection device was installed within the hotel's Heating Ventilation Air-Conditioning (HVAC) system at the point where air from the lobby and the common areas are circulated back in to the building. An inlet head that captures particles smaller than three microns was placed in the main exhaust duct from the lobby and fed directly into the ASD. Air traveling through the duct at 16.1 feet per minute will be sampled on an hourly basis for the presence of bacterial spores. We expect that collected samples will provide valuable scientific data about background bacterial spore levels in the air. The company will use the data to closely monitor and study the performance of the machine in a non-controlled setting. At the hotel's request, the specific identity and location of the hotel cannot be disclosed, however, the Company can disclose that the detection devise was installed in one of the most well known internationally branded hotel chains.
"The installation of UDTT's Anthrax Smoke Detector at a large scale hotel with huge traffic is a major milestone in our marketing efforts which we initially have targeted to larger venues," says Jacques Tizabi, UDTT chairman and CEO.
About Universal Detection Technology
Universal Detection Technology (UDTT), founded in 1973, is a developer of monitoring technologies, including bio-terrorism detection devices. Management believes that the Company's technology, together with third-party technologies and devices, has positioned it to capitalize on growth and value opportunities related to Homeland Security. UDTT, in cooperation with NASA's Jet Propulsion Laboratory (JPL), has developed a bio-terror 'smoke' detector, which combines JPL's spore detection technology with UDTT's aerosol capture device.
For more information, please visit http://udtt.invrel.net or http://www.udetection.com.
Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt, our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market, our ability to commercially produce our products on a profitable basis, commercial acceptance of our products, product price volatility, product demand, market competition and general economic conditions, and other factors described in the Company's filings with the Securities and Exchange Commission. We undertake no obligation and do not intend to revise or update publicly any forward looking statements for any reason.